Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
|
|
18.
|
|
|
19.
|
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer. [electronic resource] by
- Munster, P N
- Thurn, K T
- Thomas, S
- Raha, P
- Lacevic, M
- Miller, A
- Melisko, M
- Ismail-Khan, R
- Rugo, H
- Moasser, M
- Minton, S E
Producer: 20110810
In:
British journal of cancer vol. 104
Availability: No items available.
|
|
20.
|
A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma. [electronic resource] by
- Thomas, S
- Aggarwal, R
- Jahan, T
- Ryan, C
- Troung, T
- Cripps, A M
- Raha, P
- Thurn, K T
- Chen, S
- Grabowsky, J A
- Park, J
- Hwang, J
- Daud, A
- Munster, P N
Producer: 20171221
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|